Lineage Cell Therapeutics, Inc. (LCTX)
1.09
+0.01
(+0.93%)
USD |
NYAM |
Sep 08, 16:00
1.10
+0.01
(+0.92%)
Pre-Market: 08:04
Lineage Cell Therapeutics Total Liabilities (Quarterly) : 46.42M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 46.42M |
| March 31, 2026 | 56.84M |
| December 31, 2025 | 69.24M |
| September 30, 2025 | 68.84M |
| June 30, 2025 | 43.69M |
| March 31, 2025 | 34.10M |
| December 31, 2024 | 36.21M |
| September 30, 2024 | 31.80M |
| June 30, 2024 | 35.93M |
| March 31, 2024 | 37.49M |
| December 31, 2023 | 39.00M |
| September 30, 2023 | 39.49M |
| June 30, 2023 | 40.43M |
| March 31, 2023 | 44.19M |
| December 31, 2022 | 51.73M |
| September 30, 2022 | 53.60M |
| June 30, 2022 | 54.42M |
| March 31, 2022 | 59.30M |
| December 31, 2021 | 83.65M |
| September 30, 2021 | 11.62M |
| June 30, 2021 | 11.15M |
| March 31, 2021 | 11.36M |
| December 31, 2020 | 12.82M |
| September 30, 2020 | 12.91M |
| June 30, 2020 | 14.39M |
| Date | Value |
|---|---|
| March 31, 2020 | 14.12M |
| December 31, 2019 | 14.23M |
| September 30, 2019 | 17.46M |
| June 30, 2019 | 19.93M |
| March 31, 2019 | 22.48M |
| December 31, 2018 | 9.414M |
| September 30, 2018 | 6.519M |
| June 30, 2018 | 7.50M |
| March 31, 2018 | 7.94M |
| December 31, 2017 | 8.978M |
| September 30, 2017 | 12.88M |
| June 30, 2017 | 15.17M |
| March 31, 2017 | 15.52M |
| December 31, 2016 | 12.06M |
| September 30, 2016 | 11.33M |
| June 30, 2016 | 10.28M |
| March 31, 2016 | 20.52M |
| December 31, 2015 | 18.21M |
| September 30, 2015 | 15.92M |
| June 30, 2015 | 14.66M |
| March 31, 2015 | 12.19M |
| December 31, 2014 | 12.18M |
| September 30, 2014 | 16.70M |
| June 30, 2014 | 19.40M |
| March 31, 2014 | 12.59M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agenus, Inc. | 378.54M |
| Amgen, Inc. | 83.95B |
| Anika Therapeutics, Inc. | 46.19M |
| BioCryst Pharmaceuticals, Inc. | 1.012B |
| Imunon, Inc. | 10.80M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 106.22M |
| Shareholders Equity (Quarterly) | 60.92M |
| Debt to Equity Ratio | 0.0377 |
| Current Ratio | 6.608 |
| Net Debt Paydown Yield | 0.00% |